methamphetamine has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blount, LR; Fan, KH; Lever, JR; Lever, SZ; Miller, DK; Rodvelt, KR | 1 |
| Blount, LR; Fan, KH; Lever, JR; Lever, SZ; Miller, DK; Oelrichs, CE; Rodvelt, KR | 1 |
| Itoh, T; Mori, T; Rahmadi, M; Shibasaki, M; Suzuki, T; Yoshizawa, K | 1 |
3 other study(ies) available for methamphetamine and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride
| Article | Year |
|---|---|
SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus.
Topics: Animals; Chromatography, High Pressure Liquid; Cocaine; Dose-Response Relationship, Drug; Locomotion; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Mice; Piperazines; Receptors, sigma | 2011 |
The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.
Topics: Animals; Brain; Central Nervous System Stimulants; Discrimination Learning; Dopamine; Drug Interactions; Ethylenediamines; Male; Methamphetamine; Motor Activity; Neostriatum; Nootropic Agents; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma | 2011 |
Inhibitory effects of SA4503 on the rewarding effects of abused drugs.
Topics: Animals; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Inhibition, Psychological; Male; Methamphetamine; Morphine; Narcotics; Nootropic Agents; Pentazocine; Piperazines; Psychomotor Performance; Rats, Inbred F344; Rats, Sprague-Dawley; Reward; Substance-Related Disorders | 2014 |